There were 1,540 press releases posted in the last 24 hours and 429,373 in the last 365 days.

World Blood Screening and Typing Markets to 2020 Featuring Grifols and Roche Diagnostics

Dublin, Feb. 29, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/h97s5m/blood_screening) has announced the addition of the "Blood Screening and Typing Markets" report to their offering.

Blood Screening and Typing Markets profiles a selection of companies that specialize in blood banking and that contribute molecular test innovation to this segment. Companies discussed include Grifols and Roche Diagnostics.

A variety of infectious agents can be present in blood, including viruses, bacteria, protozoans, Chagas disease, Lyme Disease, and prions. Blood typing and testing represents the cornerstone of ensuring that transfused blood is safe for the recipient and free of disease.

Blood Screening and Typing Markets examines the infectious disease blood typing and the infectious disease blood screening markets, including complete market analysis of the blood screening and typing markets:

  • Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
  • Selected Blood Typing Innovations
  • Blood Typing by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Infectious Disease Blood Typing Market Share by Company
  • Immunoassay Testing Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Selected New Blood Screening Immunoassays
  • NAT Blood Screening Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Selected New Blood Screen NAT Tests and Systems
  • Infectious Disease Blood Screening Test Market Share by Company

The report provides a comprehensive overview of the blood screening and typing markets, discussing:

  • Risk of Contamination
  • Viral Inactivation by Procedure
  • Basic Blood Types
  • Blood Transfusion Compatibility
  • PCR-Based Screening Tests Licensed by CBER
  • Comparison of Direct and Indirect ELISA Tests
  • Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries
  • Blood Component Usage
  • Pathogens Commonly Tested in Donated Blood Units
  • Selected Pathogen Screening Innovations

Key Topics Covered:

ONE: EXECUTIVE SUMMARY
Blood Screening
Blood Typing
The Market for Blood Testing and Typing

TWO: INTRODUCTION
Reducing Blood Typing Errors
Improving Donor Screening
Improving Viral Screening
Increasing Repeat Donation Rates
Enhancing Viral Inactivation Processes
Increasing Voluntary Donation
Preventing Bacterial Infections
Biovigilance
Other Safety Precautions
Blood Typing
Methods of Blood Typing
Blood Testing
Nucleic Acid Amplification Testing (NAT)
CBER Licensed NAT Screening Tests
Polymerase Chain Reaction (PCR) Amplification
CBER Licensed PCR Screening Tests
Immunoassay
Enzyme-Linked Immunosorbent Assay
Costs and Other Barriers
Blood Storage
Blood Transfusions
Blood Pathogen Screening

THREE: MARKET ANALYSIS
Blood Banking Gets a Shakeup
Blood Typing
Blood Grouping and Typing
Immunoassays
Nucleic Acid Testing (NAT)
Market Share in Blood Testing

FOUR: COMPANY PROFILES
Abbott Diagnostics
AXO Science
Beckman Coulter
bioMérieux Inc
Cerus Corporation
DiaSorin S.p.A
Grifols
Blood Transfusion Novartis Business
International Programs
Haemonetics Corporation
Hologic, Inc.
Product News
The Gen-Probe Business
Panther System
Blood Bank
Quest Contract
Immucor, Inc.
Immunetics Inc.
Ortho Clinical Diagnostics
Quotient Limited
Roche Diagnostics
Terumo BCT
Verax Biomedical Inc.

For more information visit http://www.researchandmarkets.com/research/h97s5m/blood_screening





CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Healthcare and Medical Devices

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.